World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
46508
World Ranking
19246
National Ranking
9588

Overview

John E. Duda is affiliated with the University of Pennsylvania in the United States and has contributed to the field of medicine, with a focus on neurology, psychiatry and mental health, and cognitive neuroscience. Their research addresses topics related to Parkinson's disease mechanisms and treatments, dementia and cognitive impairment, as well as complementary and alternative medicine studies.

The scientist has published several papers on these subjects, including:

  • "Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?" (2020, Movement Disorders)
  • "Research Priorities of Individuals and Caregivers With Lewy Body Dementia" (2023, Alzheimer Disease & Associated Disorders)
  • "Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease" (2020, Journal of Parkinson s Disease)
  • "Lewy Body Dementia: Caregiver Burden and Unmet Needs" (2020, UNC Libraries)
  • "Lewy body dementia: The caregiver experience of clinical care" (2020, UNC Libraries)

John E. Duda frequently collaborates with several co-authors, including Jacqueline Rick, Sharon X. Xie, Nabila Dahodwala, Alice Chen-Plotkin, and James F. Morley, each with multiple joint publications.

Their work often appears in various publication venues, with a notable presence in UNC Libraries, Movement Disorders, Alzheimer Disease & Associated Disorders, and the Journal of Parkinson s Disease. They also have publications on bioRxiv (Cold Spring Harbor Laboratory).

The scientist's multidisciplinary research spans significant neurological and cognitive health challenges, focusing on complex disorders such as Parkinson's disease and Lewy body dementia. This research addresses both the clinical aspects of these diseases as well as the experiences and needs of caregivers.

Best Publications

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

    Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins

  • Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

    I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions

    Benoit I. Giasson;John E. Duda;Ian V. J. Murray;Qiping Chen

  • Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial

    Frances M. Weaver;Frances M. Weaver;Kenneth Follett;Matthew Stern;Matthew Stern;Kwan Hur

  • Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

    Kenneth A. Follett;Kenneth A. Follett;Frances M. Weaver;Matthew Stern;Kwan Hur

  • Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

    S. Hoops;S. Nazem;A. D. Siderowf;J. E. Duda

  • Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein

    Benoit I. Giasson;John E. Duda;John E. Duda;Shawn M. Quinn;Bin Zhang

  • Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.

    Dennis W Dickson;Heiko Braak;John E Duda;Charles Duyckaerts

  • Association of dopamine agonist use with impulse control disorders in Parkinson disease.

    Daniel Weintraub;Andrew D. Siderowf;Marc N. Potenza;Joseph Goveas

  • Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated

    John L Robinson;Edward B Lee;Sharon X Xie;Lior Rennert

  • DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

    C. F. Lippa;J. E. Duda;M. Grossman;H. I. Hurtig

  • Neuropathologic substrates of Parkinson disease dementia.

    David J. Irwin;Matthew T. White;Jon B. Toledo;Sharon X. Xie

  • Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease

    Daniel Weintraub;Staci Hoops;Judy A. Shea;Judy A. Shea;Kelly E. Lyons

  • Neuropathological and Genetic Correlates of Survival and Dementia Onset in Synucleinopathies: A Retrospective Analysis

    David J Irwin;Murray Grossman;Daniel Weintraub;Daniel Weintraub;Howard I Hurtig

  • Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.

    Frances M. Weaver;Frances M. Weaver;Kenneth A. Follett;Matthew B. Stern;Matthew B. Stern;Ping Luo

  • Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

    Hanae Nakashima-Yasuda;Kunihiro Uryu;John Robinson;Sharon X. Xie

  • Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease

    Daniel Weintraub;Paul J. Moberg;John E. Duda;Ira R. Katz

  • Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases

    John E. Duda;Benoit I. Giasson;Meghann E. Mabon;Virginia M.-Y. Lee

  • Montreal Cognitive Assessment Performance in Patients with Parkinson’s Disease with “Normal” Global Cognition According to Mini-Mental State Examination Score

    Sarra Nazem;Andrew D. Siderowf;John E. Duda;Tom Ten Have

Frequent Co-Authors

Daniel Weintraub
Daniel Weintraub University of Pennsylvania
Matthew B. Stern
Matthew B. Stern University of Pennsylvania
Andrew Siderowf
Andrew Siderowf University of Pennsylvania
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Howard I. Hurtig
Howard I. Hurtig University of Pennsylvania
Virginia M.-Y. Lee
Virginia M.-Y. Lee University of Pennsylvania
Sharon X. Xie
Sharon X. Xie University of Pennsylvania
Benoit I. Giasson
Benoit I. Giasson University of Florida
David J. Irwin
David J. Irwin University of Pennsylvania
Murray Grossman
Murray Grossman University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative health care career paths can be a smart move for those interested in medicine. Online programs make it easier than ever to earn advanced nursing credentials and diversify your options. If you’re considering a clinical leadership or teaching role, dnp online programs offer flexible study schedules and fast-track pathways for busy professionals.

For those looking for less intensive entry points, the 9 month lpn program is an efficient way to get licensed quickly and start gaining practical experience in the healthcare field. If you want insight from real students, exploring the easiest dnp program reddit discussions can help you understand program workloads and requirements.

There's also growing demand in mental health services. For those interested in specialized practice, psychiatric np programs offer a focused route to become a mental health nurse practitioner—often available as online courses for added convenience. All of these pathways provide alternatives to traditional medical degrees while supporting a vital role in today’s healthcare system.

Best Scientists Citing John E. Duda

Trending Scientists